Corrigendum to Commission Delegated Regulation (EU) 2020/1737 of 14 July 2020 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (Official Journal of the European Union L 392 of 23 November 2020)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/corrigendum/oj/L/2021/282/07@2020-07-14/en
On page 5, in Annex I, in the amendments to Annex I and II to Regulation (EC) 273/2004: for: read:
corr_1
(c) in the entry for Anthranilic acid in the table SUBCATEGORY 2B, the CN code 29224300 is replaced by ex29224300;,
(c) in the entry for Anthranilic acid in the table SUBCATEGORY 2B, the CN code 29224300 is replaced by 29224300;.
On page 7, in Annex II, in the amendments to the Annex to Regulation (EC) No 111/2005 for: read:
corr_2
(2) the table Category 2 is amended as follows:
(2)
(a) in the entry for Anthranilic acid, the CN code 29224300 is replaced by ex29224300;,
(2) the table Category 2 is amended as follows:
(2)
(a) in the entry for Anthranilic acid, the CN code 29224300 is replaced by 29224300;.